This 2018 systematic review published in Current Topics in Medicinal Chemistry (PMID: 30430944) examines the role of increased intestinal permeability—commonly referred to as leaky gut—in the development of neuroimmune disorders such as major depressive disorder (MDD), chronic fatigue syndrome (CFS), schizophrenia, and irritable bowel syndrome (IBS). The review highlights a
